AGP Sues Correlogic; Claims Company Defaulted on Loan by Misrepresenting OvaCheck Test

In its suit the company asserted that the alleged misrepresentations put Correlogic in default on a $750,000 loan from AGP, and that as a result Correlogic is required under the loan agreement to grant AGP an exclusive license for the use of its intellectual property in Asia.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.